About
IBScreen is a leading provider of innovative screening solutions and services for drug discovery and development. With a focus on cutting-edge technologies and scientific expertise, IBScreen offers a comprehensive range of products and services to support pharmaceutical companies, biotechnology firms, and academic research institutions worldwide. Their commitment to quality, reliability, and customer satisfaction has made them a trusted partner for drug discovery and preclinical research.

Products
- Compound Libraries:
- Screening Libraries: Diverse collections of small molecule compounds for high-throughput screening (HTS) and lead discovery programs.
- Focused Libraries: Targeted libraries designed to address specific therapeutic areas, pathways, or target classes, accelerating hit identification and optimization.
- Assay Kits and Reagents:
- Biochemical Assays: Ready-to-use assay kits for measuring enzyme activity, protein-protein interactions, and other biochemical processes.
- Cell-Based Assays: Assay kits for cell viability, proliferation, apoptosis, and other cellular functions, compatible with various cell types and assay formats.
- Custom Screening Compounds:
- Synthetic Chemistry: Custom synthesis of small molecules, scaffolds, and analogs tailored to specific research needs and screening requirements.
- Fragment Libraries: Fragment-based screening libraries containing low molecular weight compounds for identifying novel drug leads and pharmacophore mapping.
- Label-Free Screening Technologies:
- Biosensor Assays: Label-free biosensor assays for real-time detection and characterization of biomolecular interactions, including protein-ligand binding and protein-protein interactions.
- High-Content Screening (HCS) Systems:
- Imaging Systems: High-content screening platforms equipped with advanced imaging capabilities for automated analysis of cellular phenotypes and drug effects.
Services
- Assay Development and Optimization:
- Biomarker Assays: Development and optimization of biomarker assays for target validation, mechanism of action studies, and biomarker discovery.
- Hit-to-Lead Optimization: Lead optimization services to improve potency, selectivity, and pharmacokinetic properties of hit compounds identified from screening campaigns.
- Compound Screening Services:
- High-Throughput Screening (HTS): Comprehensive HTS services using state-of-the-art screening platforms and assay technologies for primary and secondary screening campaigns.
- Fragment Screening: Fragment-based screening services for identifying low molecular weight hits and lead compounds using biophysical and biochemical assays.
- Data Analysis and Interpretation:
- Bioinformatics Support: Data analysis, visualization, and interpretation services for screening data, including hit selection, SAR analysis, and structure-activity relationship modeling.
Location:
IBScreen is headquartered in Moscow, Russia, with laboratories and facilities equipped with advanced screening technologies and automation systems for drug discovery and preclinical research.
Contact Information:
IBScreen is committed to advancing drug discovery and development through innovative screening solutions and services. Their multidisciplinary team of scientists and experts collaborates closely with clients to accelerate research efforts and facilitate the identification of novel drug candidates for a wide range of therapeutic indications.